| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 348.57B | 369.02B | 372.48B | 255.86B | 226.56B | 217.42B |
| Gross Profit | 145.95B | 136.73B | 145.76B | 76.21B | 77.51B | 74.40B |
| EBITDA | 51.04B | 59.21B | 72.22B | 18.99B | 27.51B | 29.41B |
| Net Income | 11.02B | 16.05B | 29.59B | -9.54B | 6.41B | 5.71B |
Balance Sheet | ||||||
| Total Assets | 433.65B | 441.65B | 469.23B | 381.27B | 363.27B | 330.61B |
| Cash, Cash Equivalents and Short-Term Investments | 60.15B | 51.58B | 35.22B | 37.59B | 52.43B | 66.24B |
| Total Debt | 85.74B | 88.75B | 97.47B | 86.65B | 56.79B | 48.29B |
| Total Liabilities | 208.45B | 205.59B | 240.57B | 185.29B | 154.66B | 134.27B |
| Stockholders Equity | 224.67B | 235.30B | 227.79B | 193.17B | 205.32B | 193.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 42.08B | 34.82B | -21.70B | 5.79B | 23.36B |
| Operating Cash Flow | 0.00 | 47.17B | 41.20B | -16.69B | 10.60B | 28.23B |
| Investing Cash Flow | 0.00 | -9.67B | -33.78B | -9.36B | -25.74B | -21.67B |
| Financing Cash Flow | 0.00 | -20.94B | -13.10B | 8.73B | -1.23B | -11.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥255.76B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
75 Outperform | ¥365.32B | 25.54 | ― | 1.01% | 14.47% | 30.85% | |
72 Outperform | ¥223.80B | 53.20 | 3.44% | 2.74% | -15.49% | -59.00% | |
71 Outperform | ¥43.65B | 6.02 | 8.36% | 2.39% | 18.14% | 83.08% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥13.12B | 33.09 | ― | 2.71% | -6.08% | -56.08% |